Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Identification of Oral Lesions Through an Autofluorescence System

NCT: NCT05942794 · COMPLETED

NCT IDNCT05942794
StatusCOMPLETED
Start Date2023-06-01
Completion2024-10-01
SponsorFederico II University (OTHER)
First posted
Last updated

Brief Summary

The aim of the study will be to evaluate the efficacy of a tissue autofluorescence detection system as an aid to clinical screening in identifying lesions of the oral mucosa. The screening process will be performed by 3 clinicians with a different level of experience. Sensitivity and specificity tests will be conducted.

Frequently Asked Questions

What is Identification of Oral Lesions Through an Autofluorescence System?

Identification of Oral Lesions Through an Autofluorescence System is a clinical trial registered under NCT05942794. Current status: COMPLETED.

What is the status of NCT05942794?

The current status of NCT05942794 (Identification of Oral Lesions Through an Autofluorescence System) is: COMPLETED.

When did Identification of Oral Lesions Through an Autofluorescence System start?

Identification of Oral Lesions Through an Autofluorescence System started on 2023-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.